CLINICAL_TRIALS
trial_result
· 2022-03-10
Clinical Trial Update: Treatment of Primary CNS Lymphoma ( FTD ) [Phase 2]
Summary
Phase 2 clinical trial update for treatment of Primary CNS Lymphoma (PCNSL) completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Mingzhi Zhang | Conditions: Primary CNS Lymphoma (PCNSL) | Phase 2 | Status: COMPLETED